Cutera, Inc. (CUTR) Upgraded to “Strong-Buy” at BidaskClub

BidaskClub upgraded shares of Cutera, Inc. (NASDAQ:CUTR) from a buy rating to a strong-buy rating in a report released on Wednesday.

A number of other equities research analysts also recently weighed in on the company. Zacks Investment Research downgraded Cutera from a hold rating to a sell rating in a research report on Thursday, May 4th. TheStreet downgraded Cutera from a b- rating to a c rating in a research report on Monday, May 1st. Sidoti restated a buy rating and issued a $30.00 target price (up from $27.00) on shares of Cutera in a research report on Saturday, June 3rd. Finally, Roth Capital started coverage on Cutera in a research report on Monday, June 26th. They issued a buy rating and a $32.00 target price for the company. Four analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Cutera has a consensus rating of Buy and a consensus price target of $31.50.

Cutera (CUTR) opened at 27.00 on Wednesday. Cutera has a one year low of $10.43 and a one year high of $29.25. The company’s 50-day moving average price is $23.01 and its 200 day moving average price is $20.36. The firm has a market capitalization of $374.17 million, a PE ratio of 103.45 and a beta of 0.60.

Cutera (NASDAQ:CUTR) last released its earnings results on Monday, May 1st. The medical device company reported ($0.07) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.07). The firm had revenue of $29.30 million during the quarter, compared to the consensus estimate of $29 million. Cutera had a return on equity of 9.21% and a net margin of 2.89%. The firm’s revenue for the quarter was up 30.8% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.16) earnings per share. On average, analysts forecast that Cutera will post $0.46 earnings per share for the current year.

WARNING: “Cutera, Inc. (CUTR) Upgraded to “Strong-Buy” at BidaskClub” was originally published by Stock Observer and is the sole property of of Stock Observer. If you are accessing this piece on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The original version of this piece can be viewed at https://www.thestockobserver.com/2017/07/18/cutera-inc-cutr-upgraded-to-strong-buy-at-bidaskclub.html.

In other news, EVP Larry Laber sold 1,000 shares of the stock in a transaction on Wednesday, June 28th. The stock was sold at an average price of $25.88, for a total transaction of $25,880.00. Following the completion of the sale, the executive vice president now owns 73,140 shares in the company, valued at approximately $1,892,863.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director David A. Gollnick sold 10,000 shares of the stock in a transaction on Monday, June 26th. The shares were sold at an average price of $25.08, for a total value of $250,800.00. Following the sale, the director now owns 26,641 shares of the company’s stock, valued at approximately $668,156.28. The disclosure for this sale can be found here. Insiders have sold a total of 160,410 shares of company stock valued at $3,410,284 in the last quarter. Insiders own 3.30% of the company’s stock.

Several large investors have recently made changes to their positions in the stock. Federated Investors Inc. PA increased its stake in shares of Cutera by 143.7% in the fourth quarter. Federated Investors Inc. PA now owns 12,568 shares of the medical device company’s stock worth $218,000 after buying an additional 7,410 shares during the period. Icon Advisers Inc. Co. bought a new stake in shares of Cutera during the first quarter worth approximately $571,000. Two Sigma Investments LP increased its stake in shares of Cutera by 16.4% in the fourth quarter. Two Sigma Investments LP now owns 53,498 shares of the medical device company’s stock worth $928,000 after buying an additional 7,519 shares during the period. Russell Investments Group Ltd. bought a new stake in shares of Cutera during the fourth quarter worth approximately $321,000. Finally, Oxford Asset Management increased its stake in shares of Cutera by 98.4% in the first quarter. Oxford Asset Management now owns 52,100 shares of the medical device company’s stock worth $1,078,000 after buying an additional 25,839 shares during the period. Institutional investors own 81.42% of the company’s stock.

About Cutera

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply